Generics Industry Gets FTC OK For Shortage Prevention Plan

Law360, New York (August 8, 2012, 7:13 PM EDT) -- A generic-drug industry proposal to share sensitive information to help avert pending medication shortages will likely not violate antitrust rules, the Federal Trade Commission said Wednesday.

The Generic Pharmaceutical Association had asked for an advisory opinion on its "accelerated recovery initiative," a program in which generics makers and distributors would voluntarily provide information about their production schedules and inventories in an effort to help federal regulators deal with drug shortages.

"Based on the information GPhA has provided, it appears that the proposed ARI program is not...
To view the full article, register now.